Age-related Macular Degeneration (AMD)

Age-related Macular Degeneration (AMD) is a leading cause of irreversible vision loss and blindness among the elderly population worldwide. This specialized conference track aims to bring together ophthalmologists, researchers, clinicians, and industry experts to discuss key topics and challenges related to AMD diagnosis, management, and therapeutic interventions.

Key Themes and Topics:

1. Pathophysiology of AMD: Explore the underlying mechanisms and molecular pathways implicated in the development and progression of AMD, including genetic predisposition, oxidative stress, and inflammation.
2. Diagnostic Modalities: Discuss the latest advancements in diagnostic imaging techniques, such as optical coherence tomography (OCT), fundus autofluorescence (FAF), and fluorescein angiography (FA), for early detection and monitoring of AMD.
3. Subtypes and Classification: Review the classification systems and subtypes of AMD, including dry AMD (non-neovascular) and wet AMD (neovascular), and their clinical implications for disease management.
4. Treatment Strategies: Evaluate the efficacy, safety, and outcomes of current treatment modalities for AMD, including anti-vascular endothelial growth factor (anti-VEGF) therapies, photodynamic therapy (PDT), and emerging pharmacological agents.
5. Nutritional Interventions: Explore the role of nutritional supplements and dietary modifications in the prevention and management of AMD, including the AREDS and AREDS2 formulations and their impact on disease progression.
6. Surgical Interventions: Discuss surgical options, such as macular translocation surgery, retinal pigment epithelial (RPE) transplantation, and submacular surgery, for advanced cases of AMD refractory to medical therapy.